Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

Technology Scientific & Technical Instruments
MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

MedMira Inc
Bullboard Posts
User Avatar Image
(46)
•••
Comment by Barrheadon May 01, 2020 4:06pm
143 Views
Post# 30977734

RE:RE:RE:RE:closing price

RE:RE:RE:RE:closing priceMIR equated to a 11.11% return on your money in ONE DAY!

MEDMIRA INC

CURRENT PRICE IS0.300(up from previous)
PRICE CHANGE+0.030
PRICE CHANGE11.11%
 
Bid Size
0.295 130
Ask Size
0.300 96
Volume
6,500,724
MIR chart
Quote as of: May 01, 2020 03:59:00 PM ET
Orders Shares Bid Ask Shares Orders
5 65,000 0.295 0.30 48,000 1
6 54,500 0.29 0.305 35,000 1
6 43,500 0.285 0.31 15,000 1
5 145,000 0.28 0.315 12,000 2
3 62,000 0.275 0.32 140,500 15


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities